GRN and neoplasm: After 20 days, tumors derived from UMUC-3/shScr control cells reached an average of 200 mm3 of tumor volume (Figure 7A); in contrast, the progranulin depleted UMUC-3/shPGRN showed a significantly reduced tumor growth (***P < 0.001, Figure 7A).